View in EDS HTML Full Text PDF Full Text

A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.

Saved in:
Bibliographic Details
Title: A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.
Authors: Dasari, Vijayendra1 (AUTHOR) Vijayendra.Dasari@qimrberghofer.edu.au, Beckett, Kirrilee1 (AUTHOR), Horsefield, Shane1 (AUTHOR), Ambalathingal, George1 (AUTHOR), Khanna, Rajiv1 (AUTHOR) Vijayendra.Dasari@qimrberghofer.edu.au
Source: PLoS Pathogens. 6/23/2022, Vol. 18 Issue 6, p1-24. 24p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1010403